Dividend19 Jun 2026, 07:40 pm
Bliss GVS Pharma: Intimation on Dividend Tax Deduction
AI Summary
Bliss GVS Pharma Ltd has issued a communication to its shareholders regarding the tax deduction on dividends. Following the abolition of dividend distribution tax and its taxation in the hands of shareholders as per the Finance Act, 2020, the company will deduct tax at source (TDS) on dividends if approved at the upcoming 41st AGM. The recommended final dividend is Re. 1.00 per equity share for FY 2025-26, with July 8, 2026, set as the record date. TDS rates will vary based on shareholder status and documentation, with specific provisions outlined for resident individuals and non-individuals, including exemptions for certain entities and thresholds.
Key Highlights
- Dividend distribution tax abolished; dividends now taxable for shareholders.
- Company to deduct TDS on recommended Re. 1 dividend per share.
- Record date set for July 8, 2026; AGM on July 15, 2026.
- TDS rates depend on residency, PAN, and submitted documentation.
- Specific TDS rules and exemptions detailed for resident shareholders.
Price Impact
More from BLISSGVS